
ALC Stock Forecast & Price Target
ALC Analyst Ratings
Bulls say
Alcon's positive outlook is supported by its increasing market share in the contact lens segment, which demonstrated year-over-year growth in 4Q24. Additionally, the company's Ocular Health sales reached $416 million, reflecting a 2% growth, while Consumables sales rose to $738 million with a strong 7% increase in the same quarter. Furthermore, Alcon's core operating margin improved to 20.1%, exceeding consensus expectations and marking a 120 basis points increase from the previous year, indicating strong operational efficiency.
Bears say
Alcon faces significant risks related to potential market share losses in both its intraocular lens (IOL) and contact lens markets, which could lead to weaker-than-expected revenue growth. The company's bear case scenario anticipates flat-to low-single digit revenue growth, coupled with minimal operating expense leverage, resulting in slower earnings per share (EPS) growth. Additionally, while Vision Care's operating margin showed improvement, the Surgical segment's operating margin declined, indicating potential challenges within its operational structure.
This aggregate rating is based on analysts' research of Alcon Inc. - Registered Shares and is not a guaranteed prediction by Public.com or investment advice.
ALC Analyst Forecast & Price Prediction
Start investing in ALC
Order type
Buy in
Order amount
Est. shares
0 shares